Phase II Trial of IH636 Grape Seed Proanthocyanidin Extract in Adverse Effects of High Dose Breast Radiotherapy
Breast Cancer · Radiation Fibrosis
Enrolment not recorded · Results not recorded
Loading the evidence…
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
Breast Cancer · Radiation Fibrosis
Enrolment not recorded · Results not recorded
Atherosclerosis of Arteries of the Extremities
Enrolment: 287 · Results not recorded
Early Stage Lung Cancer (I and II)
Enrolment: 6 · Results not recorded
Breast Cancer
Enrolment: 37 · Results not recorded
Triglyceride Metabolism · Cardiovascular Function
Enrolment: 16 · Results not recorded
Cardiovascular Diseases · Circadian Rhythm Sleep Disorder, Shift Work Type · Cholesterol Level, High
Enrolment: 22 · Results not recorded
Iron Deficiency Anemia · Iron-deficiency
Enrolment: 11 · Results not recorded
Cognitive Function · Mood
Enrolment: 60 · Results not recorded
Deep Carious Lesions
Enrolment: 60 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Standardised contusion injury of the gastrocnemius muscle
Proanthocyanidolic oligomers brought satellite cell activation forward to 4 h post-contusion, abolished the neutrophil rise, shifted the macrophage response earlier with resolution by day 5, raised IL-10 at day 3, and completed muscle fibre regeneration by day 14 whereas placebo animals had not.
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.68. Machine-extracted fields require source verification.